고성능 액체 크로마토그래피 시장 : 제품 유형별, 용도별, 최종 용도별, 예측(2024-2032년)

High-performance liquid chromatography market size will register a 5.3% CAGR between 2024 and 2032 driven by increasing demand for precise and efficient analytical techniques in pharmaceutical and biotechnological research. The rise in chronic diseases and the consequent need for novel drug discoveries is propelling the demand for advanced HPLC (high performance liquid chromatography) systems in the pharmaceutical industry. As per reports, around one-third of all adults experienced multiple chronic conditions.

Regulatory bodies worldwide are also enforcing stringent guidelines for contaminant and pollutant levels in the environment and food products, further necessitating reliable and sensitive analytical methods. The capability to detect trace amounts of contaminants and adulterants also makes liquid chromatography an indispensable tool for compliance with these regulations. The continuous advancements in HPLC technology, including the development of ultra-high-performance liquid chromatography (UHPLC) systems and improved detection methods will further drive the market growth.

The overall industry is divided into product type, application, end-user, and region.

HPLC market from the consumables & accessories product type segment is slated to record strong growth through 2032 due to their essential role in supporting continuous operation and efficiency. Consumables, such as columns, filters, vials, and solvents are critical components required for sample preparation, separation, and detection processes in analysis. Advancements in consumable technologies, such as stationary phases are also enhancing the chromatographic performance, sensitivity, and reproducibility, further driving the segment growth.

With respect to end-use, the high-performance liquid chromatography market from the clinical laboratories segment is projected to observe a substantial CAGR during 2024-2032 owing to the crucial role in clinical diagnostics and research. HPLC is widely utilized in clinical laboratories for analyzing biomarkers, pharmaceutical compounds, vitamins, hormones, and metabolites with high sensitivity and precision. It also enables healthcare professionals to diagnose diseases, monitor therapeutic drug levels, and conduct pharmacokinetic studies effectively.

Asia Pacific high-performance liquid chromatography industry will witness a robust growth rate between 2024 and 2032. Rapid economic development in countries like China, India, and Japan is spurring investments in pharmaceutical R&D activities, fueling the demand for advanced analytical technologies. These countries are also increasingly focusing on drug discovery, quality control, and regulatory compliance in pharmaceutical manufacturing, stimulating regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 High accuracy and precision in analytical results
    • 3.2.1.2 Advancements in HPLC technologies
    • 3.2.1.3 Growing importance of HPLC tests in drug approvals
    • 3.2.1.4 Rise in R&D spending
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Lack of skilled professionals
    • 3.2.2.2 High cost of HPLC systems
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
  • 5.2.1 HPLC systems
  • 5.2.2 Pumps
  • 5.2.3 Detectors
  • 5.2.4 Other instruments
• 5.3 Consumables & accessories
  • 5.3.1 Columns
    • 5.3.1.1 Reverse-phase HPLC columns
    • 5.3.1.2 Normal-phase HPLC Columns
    • 5.3.1.3 Ion exchange HPLC columns
    • 5.3.1.4 Other HPLC columns
  • 5.3.2 Filters
  • 5.3.3 Vials
  • 5.3.4 Tubes
  • 5.3.5 Other consumables & accessories

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Clinical research applications
• 6.3 Diagnostic applications
• 6.4 Forensic applications
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pharmaceutical & biotechnology companies
• 7.3 Clinical laboratories
• 7.4 Academic & research institutions
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Agilent Technologies Inc.
• 9.2 Bio-Rad Laboratories Inc.
• 9.3 Gilson Incorporated
• 9.4 Hamilton Company
• 9.5 Hitachi High-Tech Corporation
• 9.6 Merck KGaA
• 9.7 Mitsubishi Chemical Group Corporation
• 9.8 PerkinElmer Inc.
• 9.9 Shimadzu Corporation
• 9.10 Thermo Fisher Scientific
• 9.11 Tosoh Corporation
• 9.12 Waters